Skip to Main Content

Paper Details

Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection.
Oncoimmunology
8
2021
Author NameAffiliation
Daniel DelittoStanford University School of Medicine
Daniel DelittoJohns Hopkins University School of Medicine
Elizabeth M JaffeeThe Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine
Elizabeth M JaffeeThe Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine
Elizabeth M JaffeeThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine
Elizabeth M JaffeeJohns Hopkins University School of Medicine
  • 1 - 6

Datasets